| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |